A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI)

This study has been completed.

Study NCT00676702 Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received: May 8, 2008 Last Updated: May 18, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2009
Primary Completion Date:	January 2009 (Final data collection date for primary outcome measure)